A
Power Law company profile
AlloVir
Biotech & Life Sciences · Lincoln, United States · Founded 2013 · IPO 2020 Unicorn
Global footprint
Where AlloVir has talent and traffic
Web traffic by country
230
monthly visits
across markets
across markets
🇺🇸 United States87%
Patent intelligence
$4M patent portfolio · 2 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$4M
548.9× smaller than top peer Ablynx ($2B)
2 active patent families
Where AlloVir innovates
Molecular biologyT cellPathologyTransplant recipientViremia
Above peer median on Market, Economic, Technology
Quality vs same-sector peers
AlloVir on the five Patsnap quality dimensions
AlloVir in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where AlloVir concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across AlloVir and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee AlloVir on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.